Company intelligence / Profile preview

Clinilabs

Eatontown, New Jersey, United Statesclinilabs.com ↗

Ownership: Private
Employees: ~236
Development stage: Commercial

Overview

Clinilabs has conducted more than 800 CNS clinical trials since its founding and contributed to the approval of over 22 new therapies across at least 13 different CNS indications. The company partners with pharmaceutical, biotechnology, and medical device companies to accelerate the development of new therapies for psychiatric, neurological, substance use, and rare/ultra-rare CNS disorders.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Clinilabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinilabs.

Explore the full profile